Journal article
Convergence of oncogenic and hormone receptor pathways promotes metastatic phenotypes
The Journal of clinical investigation, v 123(1), pp 493-508
02 Jan 2013
PMID: 23257359
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Cyclin D1b is a splice variant of the cell cycle regulator cyclin D1 and is known to harbor divergent and highly oncogenic functions in human cancer. While cyclin D1b is induced during disease progression in many cancer types, the mechanisms underlying cyclin D1b function remain poorly understood. Herein, cell and human tumor xenograft models of prostate cancer were utilized to resolve the downstream pathways that are required for the protumorigenic functions of cyclin D1b. Specifically, cyclin D1b was found to modulate the expression of a large transcriptional network that cooperates with androgen receptor (AR) signaling to enhance tumor cell growth and invasive potential. Notably, cyclin D1b promoted AR-dependent activation of genes associated with metastatic phenotypes. Further exploration determined that transcriptional induction of
SNAI2
(Slug) was essential for cyclin D1b–mediated proliferative and invasive properties, implicating Slug as a critical driver of disease progression. Importantly, cyclin D1b expression highly correlated with that of Slug in clinical samples of advanced disease. In vivo analyses provided strong evidence that Slug enhances both tumor growth and metastatic phenotypes. Collectively, these findings reveal the underpinning mechanisms behind the protumorigenic functions of cyclin D1b and demonstrate that the convergence of the cyclin D1b/AR and Slug pathways results in the activation of processes critical for the promotion of lethal tumor phenotypes.
Metrics
Details
- Title
- Convergence of oncogenic and hormone receptor pathways promotes metastatic phenotypes
- Creators
- Michael A Augello - Department of Cancer Biology andCraig J Burd - Department of Cancer Biology andRuth Birbe - Department of Cancer Biology andChristopher McNair - Department of Cancer Biology andAdam Ertel - Department of Cancer Biology andMichael S Magee - Department of Cancer Biology andDaniel E Frigo - Department of Cancer Biology andKari Wilder-Romans - Department of Cancer Biology andMark Shilkrut - Department of Cancer Biology andSumin Han - Department of Cancer Biology andDanielle L Jernigan - Department of Cancer Biology andJeffry L Dean - Department of Cancer Biology andAlessandro Fatatis - Department of Cancer Biology andDonald P McDonnell - Department of Cancer Biology andTapio Visakorpi - Department of Cancer Biology andFelix Y Feng - Department of Cancer Biology andKaren E Knudsen - Department of Cancer Biology and
- Publication Details
- The Journal of clinical investigation, v 123(1), pp 493-508
- Publisher
- American Society for Clinical Investigation
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Pharmacology and Physiology
- Web of Science ID
- WOS:000313598500050
- Scopus ID
- 2-s2.0-84873872188
- Other Identifier
- 991014878010104721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- International collaboration
- Web of Science research areas
- Medicine, Research & Experimental